Research study Program year 2021 Source: CMS Open Payments

Expanded Access Global Study for Loxo-292 - Title Pending

Research payments

$3,115,595

71 payments

Through program year 2021, $3,115,595 in research payments was reported against Expanded Access Global Study for Loxo-292 - Title Pending, across 71 payments, paid by Eli Lilly and Company.

Paid by
Eli Lilly and Company
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2021 Research $1,435,470 27
2020 Research $1,618,130 40
2019 Research $61,995 4

Breakdown

Who paid Research payments · program years 2019–2021
  1. Eli Lilly and Company $3,115,595 71 payments
Who received the money Research payments · program years 2019–2021
  1. Dana Farber Partners Cancer Care INC Organisation paid for research $519,776 3 payments
  2. Memorial Sloan-Kettering Organisation paid for research $329,652 2 payments
  3. Ut Md Anderson Cancer Center Teaching hospital · TX $295,808 2 payments
  4. Hospital Of The Univ Of Penna Teaching hospital · PA $186,554 2 payments
  5. Emory University Hospital Teaching hospital · GA $165,122 2 payments
  6. Langley Porter Psychiatric Hospital Teaching hospital · CA $154,204 2 payments
  7. University of Chicago Organisation paid for research $130,936 2 payments
  8. Mayo Clinic Organisation paid for research $117,636 2 payments
  9. Memorial Regional Hospital Teaching hospital · FL $116,918 2 payments
  10. Fairfax-Northern Virginia Organisation paid for research $106,189 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record